Type 2 Diabetes in Adults: Management – NICE Guideline NG28 (Updated February 2026)

UKKA BP in dialysis visual abstract

Very practical UK Kidney Association guidelines for management of BP in Dialysis
www.kireports.org/article/S246...
KI Reports

Here is today’s #eyeSCANdy! Collecting duct showing ostia of an entering distal tubule.  

Photo courtesy of Dr. Stephen Bonsib. #renal #pathology #kidneypath

Microscopy image of a kidney only showing the highly branched arterial tree in magenta against a black background.

The beauty of the kidney arterial tree for this #FluorescenceFriday. Evans Blue dye labels the vasculature. Image courtesy of postdoc Sarah McLarnon.

Nephrology Image
Bilateral intrarenal aneurysms in anti-GBM/ANCA overlap syndrome

doi.org/10.1016/j.kint.2025.05.038

#MedSky #NephSky

A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy

doi.org/10.1016/j.kint.2025.11.017

#OpenAccess #MedSky #NephSky #IgAN

Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction

doi.org/10.1016/j.kint.2025.12.011

#OpenAccess #MedSky #NephSky #AfricanTurquoisekillifish #SGLT2i

New from #NephFellow Dr Tomasi and PD Dr Sparks and colleagues in Rheumatology

Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritis

https://pubmed.ncbi.nlm.nih.gov/41452750/

Commentary
Berger disease redux
Richard J Glassock

doi.org/10.1016/j.kint.2025.09.021

Original article: doi.org/10.1016/j.kint.2025.07.038

#MedSky #NephSky

And if there's double contour of BM what is that called ?

Membranoproliferative glomerulonephritis with diffuse lobular simplification of the glomeruli, caused by extensive endocapillary hypercellularity (Jones silver stain).

#RenalPath: Membranoproliferative glomerulonephritis (MPGN) is a lesion caused by subendothelial immune complex deposits.

bit.ly/4azajpy (FREE)

Hyperkalemia With Empagliflozin and Finerenone | Docwire News Joel Topf, MD, interviewed Rajiv Agarwal, MBBS, about an implementation analysis of CONFIDENCE findings on hyperkalemia with finerenone and empagliflozin in chronic kidney disease.

👀 WATCH NOW: Joel Topf @kidneyboy.bsky.social caught up with Rajiv Agarwal at #KidneyWk in Houston, where the latter presented CONFIDENCE findings on implementation of finerenone and empagliflozin. #nephrology #nephsky #kidneydisease #hyperkalemia #sglt2 www.docwirenews.com/post/hyperka...

Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social
#Nephpearls #KidneyWk #NephSky

👉 www.kireports.org/article/S246...

Why high dose of it if compared to dose in IgA

eGFR outcomes why differ than IgA in spite of proteinurea reduction

Ischemia-reperfusion injury (IRI) is an unavoidable consequence of kidney transplantation, can targeting complement activated via the lectin and alternative pathways help reduce IRI and its clinical impact? Read more in this #ASNJASN #Review kidney.pub/JASN0826

CRS related or immune related podocytopathy

2025 Concise Clinical Guidance:
An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health

by Drs. Gilbert, @drmarthagulati.bsky.social, Gluckman, @mkittlesonmd.bsky.social, Rikhi, Saseen, Tchang

What are the best practices for treating patients receiving peritoneal dialysis while hospitalized? This #ASNCJASN "Kidney Case Conference: How I Treat" shares clinician perspective on protocol and procedure. kidney.pub/CJASN0783

NO more with ACEi or ARBs

Effect of losartan on endothelial function in women with history of #preeclampsia

🔗 academic.oup.com/ajh/article/... 🔓

#OpenAccess #Free

Join us for this Global Renal Exercise Group (GREX) Webinar about intradialytic exercise on July 17th. Free registration at: us06web.zoom.us/webinar/regi...

PREVAIL Investigator on Felzartamab’s Potential to Change IgAN Therapy | Docwire News Dr. George Newman of Knoxville Kidney Center discussed the PREVAIL study of felzartamab for IgA nephropathy (IgAN). Dr. Newman is a site PI for the trial.

CHECK OUT our interview with Dr. George Edward Newman, a PI for the #PREVAIL trial of #felzartamab for #IgAN. His Knoxville site recently dosed its first patient. #nephrology #nephsky #iganephropathy www.docwirenews.com/post/prevail...

Good luck

Tirzepatide associated with 1ml/min/yr slower decline in eGfR crcys and decreased albuminuria (30% in those with baseline albuminuria, less for those with normoalbuminuria)! #ada2025

Also PPI could have a roll

American Society of Nephrology | Media Library - <asp:Literal id=

www.asn-online.org/media/podcas...

Some conclusions from a great talk on monoclonal gammopathies of renal significance from Dr. Nasr at @glomcon.org today:

More on BEDMED:
youtu.be/mqkTYElw0fo?...
With @rickyturgeon.bsky.social Dr. Scott Garrison @hswapnil.medsky.social and Dr. Isla Mackenzie
@markusathome.bsky.social

𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial. 2025 from @kidneyint.bsky.social www.kidney-internati...

#VideoAbstract by @drsumanbehera.bsky.social